Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Geissler

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Nature Medicine|April 20, 2022
Delivering precision oncology to patients with cancerJoaquin Mateo, Lotte Steuten, Philippe Aftimos, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 20, 2022
Building a Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology Added Value Framework for Hematologic Malignancies: A Comparative Analysis of Existing ToolsFrancesco Cerisoli, Farzad Ali, Tamás Bereczky, et al.
Clinical Trials (London, England)|February 26, 2026
Shaping the future of clinical trials through strategic foresightSharon Lee, Jeff McIntyre, Tracey Robertson, et al.
The Lancet. Oncology|September 4, 2025
Importance of responder criteria for reporting health-related quality-of-life data in clinical trials for advanced cancer: recommendations of Common Sense Oncology and the European Organisation for Research and Treatment of CancerIan F Tannock, Madeline Lee Pe, Christopher M Booth, et al.
Journal of Cancer Policy|May 13, 2022
The European Code of Cancer PracticeMark Lawler, Kathy Oliver, Stefan Gijssels, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 9, 2023
An inter-specialty cancer training programme curriculum for EuropeKim Benstead, Andreas Brandl, Ton Brouwers, et al.
The Lancet. Oncology|October 1, 2011
Delivering affordable cancer care in high-income countriesRichard Sullivan, Jeffrey Peppercorn, Karol Sikora, et al.
The Lancet. Haematology|June 17, 2018
Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignanciesGita Thanarajasingam, Lori M Minasian, Frederic Baron, et al.
The Lancet. Haematology|April 28, 2022
Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignanciesGita Thanarajasingam, Lori M Minasian, Vishal Bhatnagar, et al.
The Lancet. Oncology|November 18, 2022
European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology CommissionMark Lawler, Lynne Davies, Simon Oberst, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Nature Medicine|April 20, 2022
Delivering precision oncology to patients with cancerJoaquin Mateo, Lotte Steuten, Philippe Aftimos, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 20, 2022
Building a Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology Added Value Framework for Hematologic Malignancies: A Comparative Analysis of Existing ToolsFrancesco Cerisoli, Farzad Ali, Tamás Bereczky, et al.
Clinical Trials (London, England)|February 26, 2026
Shaping the future of clinical trials through strategic foresightSharon Lee, Jeff McIntyre, Tracey Robertson, et al.
The Lancet. Oncology|September 4, 2025
Importance of responder criteria for reporting health-related quality-of-life data in clinical trials for advanced cancer: recommendations of Common Sense Oncology and the European Organisation for Research and Treatment of CancerIan F Tannock, Madeline Lee Pe, Christopher M Booth, et al.
Journal of Cancer Policy|May 13, 2022
The European Code of Cancer PracticeMark Lawler, Kathy Oliver, Stefan Gijssels, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 9, 2023
An inter-specialty cancer training programme curriculum for EuropeKim Benstead, Andreas Brandl, Ton Brouwers, et al.
The Lancet. Oncology|October 1, 2011
Delivering affordable cancer care in high-income countriesRichard Sullivan, Jeffrey Peppercorn, Karol Sikora, et al.
The Lancet. Haematology|June 17, 2018
Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignanciesGita Thanarajasingam, Lori M Minasian, Frederic Baron, et al.
The Lancet. Haematology|April 28, 2022
Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignanciesGita Thanarajasingam, Lori M Minasian, Vishal Bhatnagar, et al.
The Lancet. Oncology|November 18, 2022
European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology CommissionMark Lawler, Lynne Davies, Simon Oberst, et al.
Pageof 5